About lifevantage corp. - LFVN
LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.
LFVN At a Glance
LifeVantage Corp.
3300 North Triumph Boulevard
Lehi, Utah 84043-6477
| Phone | 1-801-432-9000 | Revenue | 182.59M | |
| Industry | Pharmaceuticals: Other | Net Income | 5.07M | |
| Sector | Health Technology | Employees | 223 | |
| Fiscal Year-end | 06 / 2027 | |||
| View SEC Filings |
LFVN Valuation
| P/E Current | 15.652 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 15.627 |
| Price to Sales Ratio | 0.434 |
| Price to Book Ratio | 2.326 |
| Price to Cash Flow Ratio | 7.75 |
| Enterprise Value to EBITDA | 8.758 |
| Enterprise Value to Sales | 0.406 |
| Total Debt to Enterprise Value | 0.133 |
LFVN Efficiency
| Revenue/Employee | 818,771.30 |
| Income Per Employee | 22,744.395 |
| Receivables Turnover | 41.724 |
| Total Asset Turnover | 2.724 |
LFVN Liquidity
| Current Ratio | 1.893 |
| Quick Ratio | 1.094 |
| Cash Ratio | 0.738 |
LFVN Profitability
| Gross Margin | 77.56 |
| Operating Margin | 3.122 |
| Pretax Margin | 3.322 |
| Net Margin | 2.778 |
| Return on Assets | 7.566 |
| Return on Equity | 14.867 |
| Return on Total Capital | 11.671 |
| Return on Invested Capital | 11.799 |
LFVN Capital Structure
| Total Debt to Total Equity | 29.379 |
| Total Debt to Total Capital | 22.708 |
| Total Debt to Total Assets | 15.888 |
| Long-Term Debt to Equity | 23.618 |
| Long-Term Debt to Total Capital | 18.255 |